Related references
Note: Only part of the references are listed.Ethionamide population pharmacokinetics/pharmacodynamics and therapeutic implications in South African adult patients with drug-resistant tuberculosis
Pierre Mugabo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients
Maxwell T. Chirehwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Cross-resistance between isoniazid and ethionamide and its strong association with mutation C-15T in Mycobacterium tuberculosis isolates from Peru
Roxana Sandoval et al.
REVISTA ARGENTINA DE MICROBIOLOGIA (2020)
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid
Suha Kadura et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
Nathan D. Hicks et al.
MBIO (2019)
Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms
Arash Ghodousi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions
Maha R. Farhat et al.
NATURE COMMUNICATIONS (2019)
Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates
M. M. Islam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan
Ruwen Jou et al.
INFECTION GENETICS AND EVOLUTION (2019)
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis
Devyani Deshpande et al.
CLINICAL INFECTIOUS DISEASES (2018)
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region
Danila V. Zimenkov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
New active leads for tuberculosis booster drugs by structure-based drug discovery
Natalie J. Tatum et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420
Nicolas Blondiaux et al.
SCIENCE (2017)
Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China
Yaoju Tan et al.
FRONTIERS IN MICROBIOLOGY (2017)
Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance
Lynne de Welzen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value
Maha R. Farhat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Efficacy and tolerability of ethionamide versus prothionamide: a systematic review
Anna Scardigli et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites
Julie Laborde et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia
Elena Y. Nosova et al.
PLOS ONE (2016)
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors
Sarah Schmidt Grant et al.
CELL CHEMICAL BIOLOGY (2016)
Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates
Johana Rueda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs
Scott K. Heysell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (-15C→T)
Florence Brossier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach
Aurelien Chollet et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs
Belen Rocio Imperiale et al.
JOURNAL OF ANTIBIOTICS (2014)
Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations
Ofer Fridman et al.
NATURE (2014)
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Nicola Casali et al.
NATURE GENETICS (2014)
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2014)
Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues
Geoffrey D. Coxon et al.
PLOS ONE (2013)
Cloning, Baeyer-Villiger Biooxidations, and Structures of the Camphor Pathway 2-Oxo-Δ3-4,5,5-Trimethylcyclopentenylacetyl-Coenzyme A Monooxygenase of Pseudomonas putida ATCC 17453
Hannes Leisch et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2012)
Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis
F. Brossier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Precise Null Deletion Mutations of the Mycothiol Synthesis Genes Reveal Their Role in Isoniazid and Ethionamide Resistance in Mycobacterium smegmatis
Xia Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan
Chiyoji Abe et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets
Lynn G. Dover et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria
Xavier Hanoulle et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Ligation independent cloning (LIC) as a rapid route to families of recombinant biocatalysts from sequenced prokaryotic genomes
D Bonsor et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2006)
Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria
C Vilchèze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates
GP Morlock et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M-bovis BCG and M-tuberculosis
MH Larsen et al.
MOLECULAR MICROBIOLOGY (2002)
The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase
TA Vannelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
AE DeBarber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
